We've found
887
archived clinical trials in
Autism
We've found
887
archived clinical trials in
Autism
An Open Label Study of CM-AT for the Treatment of Children With Autism
Updated: 12/31/1969
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated: 12/31/1969
An Open Label Study of CM-AT for the Treatment of Children With Autism
Updated: 12/31/1969
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
An Open Label Study of CM-AT for the Treatment of Children With Autism
Updated: 12/31/1969
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated: 12/31/1969
An Open Label Study of CM-AT for the Treatment of Children With Autism
Updated: 12/31/1969
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
An Open Label Study of CM-AT for the Treatment of Children With Autism
Updated: 12/31/1969
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated: 12/31/1969
An Open Label Study of CM-AT for the Treatment of Children With Autism
Updated: 12/31/1969
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
An Open Label Study of CM-AT for the Treatment of Children With Autism
Updated: 12/31/1969
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated: 12/31/1969
An Open Label Study of CM-AT for the Treatment of Children With Autism
Updated: 12/31/1969
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
An Open Label Study of CM-AT for the Treatment of Children With Autism
Updated: 12/31/1969
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated: 12/31/1969
An Open Label Study of CM-AT for the Treatment of Children With Autism
Updated: 12/31/1969
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
An Open Label Study of CM-AT for the Treatment of Children With Autism
Updated: 12/31/1969
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated: 12/31/1969
An Open Label Study of CM-AT for the Treatment of Children With Autism
Updated: 12/31/1969
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
An Open Label Study of CM-AT for the Treatment of Children With Autism
Updated: 12/31/1969
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated: 12/31/1969
An Open Label Study of CM-AT for the Treatment of Children With Autism
Updated: 12/31/1969
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
An Open Label Study of CM-AT for the Treatment of Children With Autism
Updated: 12/31/1969
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated: 12/31/1969
An Open Label Study of CM-AT for the Treatment of Children With Autism
Updated: 12/31/1969
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
An Open Label Study of CM-AT for the Treatment of Children With Autism
Updated: 12/31/1969
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated: 12/31/1969
An Open Label Study of CM-AT for the Treatment of Children With Autism
Updated: 12/31/1969
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
An Open Label Study of CM-AT for the Treatment of Children With Autism
Updated: 12/31/1969
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated: 12/31/1969
An Open Label Study of CM-AT for the Treatment of Children With Autism
Updated: 12/31/1969
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
An Open Label Study of CM-AT for the Treatment of Children With Autism
Updated: 12/31/1969
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated: 12/31/1969
An Open Label Study of CM-AT for the Treatment of Children With Autism
Updated: 12/31/1969
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
An Open Label Study of CM-AT for the Treatment of Children With Autism
Updated: 12/31/1969
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated: 12/31/1969
An Open Label Study of CM-AT for the Treatment of Children With Autism
Updated: 12/31/1969
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
An Open Label Study of CM-AT for the Treatment of Children With Autism
Updated: 12/31/1969
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated: 12/31/1969
An Open Label Study of CM-AT for the Treatment of Children With Autism
Updated: 12/31/1969
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
An Open Label Study of CM-AT for the Treatment of Children With Autism
Updated: 12/31/1969
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated: 12/31/1969
An Open Label Study of CM-AT for the Treatment of Children With Autism
Updated: 12/31/1969
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
An Open Label Study of CM-AT for the Treatment of Children With Autism
Updated: 12/31/1969
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated: 12/31/1969
An Open Label Study of CM-AT for the Treatment of Children With Autism
Updated: 12/31/1969
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
An Open Label Study of CM-AT for the Treatment of Children With Autism
Updated: 12/31/1969
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated: 12/31/1969
An Open Label Study of CM-AT for the Treatment of Children With Autism
Updated: 12/31/1969
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
An Open Label Study of CM-AT for the Treatment of Children With Autism
Updated: 12/31/1969
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated: 12/31/1969
An Open Label Study of CM-AT for the Treatment of Children With Autism
Updated: 12/31/1969
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
An Open Label Study of CM-AT for the Treatment of Children With Autism
Updated: 12/31/1969
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated: 12/31/1969
An Open Label Study of CM-AT for the Treatment of Children With Autism
Updated: 12/31/1969
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
An Open Label Study of CM-AT for the Treatment of Children With Autism
Updated: 12/31/1969
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated: 12/31/1969
An Open Label Study of CM-AT for the Treatment of Children With Autism
Updated: 12/31/1969
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
An Open Label Study of CM-AT for the Treatment of Children With Autism
Updated: 12/31/1969
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated: 12/31/1969
An Open Label Study of CM-AT for the Treatment of Children With Autism
Updated: 12/31/1969
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
An Open Label Study of CM-AT for the Treatment of Children With Autism
Updated: 12/31/1969
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated: 12/31/1969
An Open Label Study of CM-AT for the Treatment of Children With Autism
Updated: 12/31/1969
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Satisfaction Rates Among Parents of Children With Autism in the ED
Updated: 12/31/1969
What Factors Effect Parental Satisfaction During Their Visit to a Pediatric Emergency Department Among Parents of Children With Autism?
Status: Enrolling
Updated: 12/31/1969
Satisfaction Rates Among Parents of Children With Autism in the ED
Updated: 12/31/1969
What Factors Effect Parental Satisfaction During Their Visit to a Pediatric Emergency Department Among Parents of Children With Autism?
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of Intranasal Ketamine for Social Impairment in Autism Spectrum Disorder
Updated: 12/31/1969
Intranasal Ketamine Use in Autism Spectrum Disorder: A Placebo-Controlled Crossover Pilot Study
Status: Enrolling
Updated: 12/31/1969
Study of Intranasal Ketamine for Social Impairment in Autism Spectrum Disorder
Updated: 12/31/1969
Intranasal Ketamine Use in Autism Spectrum Disorder: A Placebo-Controlled Crossover Pilot Study
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Observational Prospective Study on Behavioral Outcomes of Children With Autism Spectrum Disorder (ASD) in Comparison to Those Without Neurodevelopmental Diagnoses
Updated: 12/31/1969
Observational Prospective Study on Behavioral Outcomes of Children With Autism Spectrum Disorder (ASD) in Comparison to Those Without Neurodevelopmental Diagnoses
Status: Enrolling
Updated: 12/31/1969
Observational Prospective Study on Behavioral Outcomes of Children With Autism Spectrum Disorder (ASD) in Comparison to Those Without Neurodevelopmental Diagnoses
Updated: 12/31/1969
Observational Prospective Study on Behavioral Outcomes of Children With Autism Spectrum Disorder (ASD) in Comparison to Those Without Neurodevelopmental Diagnoses
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Autism MEAL Plan: Parent Training to Manage Eating Aversions & Limited Variety
Updated: 12/31/1969
Autism MEAL Plan: Parent Training to Manage Eating Aversions & Limited Variety
Status: Enrolling
Updated: 12/31/1969
Autism MEAL Plan: Parent Training to Manage Eating Aversions & Limited Variety
Updated: 12/31/1969
Autism MEAL Plan: Parent Training to Manage Eating Aversions & Limited Variety
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Improving Autism Screening With Brain-Related miRNA
Updated: 12/31/1969
Improving Autism Screening With Brain-Related miRNA
Status: Enrolling
Updated: 12/31/1969
Improving Autism Screening With Brain-Related miRNA
Updated: 12/31/1969
Improving Autism Screening With Brain-Related miRNA
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Predictors of Caregiver Adaptation to Pervasive Developmental Disorders
Updated: 12/31/1969
Understanding Caregiver Adaptation to Pervasive Developmental Disorders
Status: Enrolling
Updated: 12/31/1969
Predictors of Caregiver Adaptation to Pervasive Developmental Disorders
Updated: 12/31/1969
Understanding Caregiver Adaptation to Pervasive Developmental Disorders
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Coping Effectiveness Training Intervention for Caregivers of Children With Autism Spectrum: A Feasibility Study
Updated: 12/31/1969
A Coping Effectiveness Training Intervention for Caregivers of Children With Autism Spectrum Disorders: A Feasibility Study
Status: Enrolling
Updated: 12/31/1969
A Coping Effectiveness Training Intervention for Caregivers of Children With Autism Spectrum: A Feasibility Study
Updated: 12/31/1969
A Coping Effectiveness Training Intervention for Caregivers of Children With Autism Spectrum Disorders: A Feasibility Study
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Metabolic Processes in Adults and Adolescents With Autism Spectrum Disorder
Updated: 12/31/1969
Study on Metabolic Processes and Cognitive Functions in Adults and Adolescents With Autism Spectrum Disorder
Status: Enrolling
Updated: 12/31/1969
Metabolic Processes in Adults and Adolescents With Autism Spectrum Disorder
Updated: 12/31/1969
Study on Metabolic Processes and Cognitive Functions in Adults and Adolescents With Autism Spectrum Disorder
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Using Serious Game Technology to Improve Sensitivity to Eye Gaze in Autism
Updated: 12/31/1969
Using Serious Game Technology to Improve Sensitivity to Eye Gaze in Autism
Status: Enrolling
Updated: 12/31/1969
Using Serious Game Technology to Improve Sensitivity to Eye Gaze in Autism
Updated: 12/31/1969
Using Serious Game Technology to Improve Sensitivity to Eye Gaze in Autism
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Neurofeedback Therapy for Children Diagnosed With Autism
Updated: 12/31/1969
Neurofeedback Therapy for Children Diagnosed With Autism
Status: Enrolling
Updated: 12/31/1969
Neurofeedback Therapy for Children Diagnosed With Autism
Updated: 12/31/1969
Neurofeedback Therapy for Children Diagnosed With Autism
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
The Multi-Media Social Skills Project for Adults
Updated: 12/31/1969
The Multi-Media Social Skills Project for Adults: Validation of an Intervention for Adults With Autism Spectrum Disorders
Status: Enrolling
Updated: 12/31/1969
The Multi-Media Social Skills Project for Adults
Updated: 12/31/1969
The Multi-Media Social Skills Project for Adults: Validation of an Intervention for Adults With Autism Spectrum Disorders
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Autism Oxytocin Brain Project
Updated: 12/31/1969
Target Engagement for Intranasal Oxytocin in Autism Spectrum Disorders, an fMRI Dose Response Study
Status: Enrolling
Updated: 12/31/1969
Autism Oxytocin Brain Project
Updated: 12/31/1969
Target Engagement for Intranasal Oxytocin in Autism Spectrum Disorders, an fMRI Dose Response Study
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Aripiprazole in Children With Autism: A Pilot Study
Updated: 12/31/1969
Aripiprazole in Children With Autism: A Pilot Study
Status: Enrolling
Updated: 12/31/1969
Aripiprazole in Children With Autism: A Pilot Study
Updated: 12/31/1969
Aripiprazole in Children With Autism: A Pilot Study
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Cord Blood Infusion for Children With Autism Spectrum Disorder
Updated: 12/31/1969
Efficacy of Intravenous Umbilical Cord Blood Infusion as Cell Therapy for Children With Autism Spectrum Disorder (ASD): Duke ACT
Status: Enrolling
Updated: 12/31/1969
Cord Blood Infusion for Children With Autism Spectrum Disorder
Updated: 12/31/1969
Efficacy of Intravenous Umbilical Cord Blood Infusion as Cell Therapy for Children With Autism Spectrum Disorder (ASD): Duke ACT
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
hCT-MSCs for Children With Autism Spectrum Disorder (ASD)
Updated: 12/31/1969
A Phase I Study of hCT-MSC, An Umbilical Cord-Derived Mesenchymal Stromal Cell Product, in Children With Autism Spectrum Disorder
Status: Enrolling
Updated: 12/31/1969
hCT-MSCs for Children With Autism Spectrum Disorder (ASD)
Updated: 12/31/1969
A Phase I Study of hCT-MSC, An Umbilical Cord-Derived Mesenchymal Stromal Cell Product, in Children With Autism Spectrum Disorder
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Autism Biomarker Consortium for Clinical Trials
Updated: 12/31/1969
Autism Biomarker Consortium for Clinical Trials
Status: Enrolling
Updated: 12/31/1969
Autism Biomarker Consortium for Clinical Trials
Updated: 12/31/1969
Autism Biomarker Consortium for Clinical Trials
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
The Effects of Video Modeling of Audiological Testing on Pediatric Patient Compliance
Updated: 12/31/1969
The Effects of Video Modeling of Audiological Testing on Pediatric Patient Compliance
Status: Enrolling
Updated: 12/31/1969
The Effects of Video Modeling of Audiological Testing on Pediatric Patient Compliance
Updated: 12/31/1969
The Effects of Video Modeling of Audiological Testing on Pediatric Patient Compliance
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Health System Integration of Tools to Improve Primary Care for Autistic Adults
Updated: 12/31/1969
Health System Integration of Tools to Improve Primary Care for Autistic Adults
Status: Enrolling
Updated: 12/31/1969
Health System Integration of Tools to Improve Primary Care for Autistic Adults
Updated: 12/31/1969
Health System Integration of Tools to Improve Primary Care for Autistic Adults
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Health System Integration of Tools to Improve Primary Care for Autistic Adults
Updated: 12/31/1969
Health System Integration of Tools to Improve Primary Care for Autistic Adults
Status: Enrolling
Updated: 12/31/1969
Health System Integration of Tools to Improve Primary Care for Autistic Adults
Updated: 12/31/1969
Health System Integration of Tools to Improve Primary Care for Autistic Adults
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Health System Integration of Tools to Improve Primary Care for Autistic Adults
Updated: 12/31/1969
Health System Integration of Tools to Improve Primary Care for Autistic Adults
Status: Enrolling
Updated: 12/31/1969
Health System Integration of Tools to Improve Primary Care for Autistic Adults
Updated: 12/31/1969
Health System Integration of Tools to Improve Primary Care for Autistic Adults
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Incredible Years Program for Parents of Children With Autism
Updated: 12/31/1969
Evaluation of Incredible Years Parenting Program for Caregivers of Children With Autism
Status: Enrolling
Updated: 12/31/1969
Incredible Years Program for Parents of Children With Autism
Updated: 12/31/1969
Evaluation of Incredible Years Parenting Program for Caregivers of Children With Autism
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Trial to Assess the Pharmacokinetics, Safety, Tolerability of Oral Brexpiprazole in Children (6 to <13 Years Old) With Central Nervous System Disorders
Updated: 12/31/1969
A Phase 1, Single-dose, Sequential Cohort, Nonrandomized Crossover Trial to Assess the Pharmacokinetics, Safety, and Tolerability of Oral Brexpiprazole in Children (6 to< 13 Years Old) With Central Nervous System Disorders
Status: Enrolling
Updated: 12/31/1969
Trial to Assess the Pharmacokinetics, Safety, Tolerability of Oral Brexpiprazole in Children (6 to <13 Years Old) With Central Nervous System Disorders
Updated: 12/31/1969
A Phase 1, Single-dose, Sequential Cohort, Nonrandomized Crossover Trial to Assess the Pharmacokinetics, Safety, and Tolerability of Oral Brexpiprazole in Children (6 to< 13 Years Old) With Central Nervous System Disorders
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Trial to Assess the Pharmacokinetics, Safety, Tolerability of Oral Brexpiprazole in Children (6 to <13 Years Old) With Central Nervous System Disorders
Updated: 12/31/1969
A Phase 1, Single-dose, Sequential Cohort, Nonrandomized Crossover Trial to Assess the Pharmacokinetics, Safety, and Tolerability of Oral Brexpiprazole in Children (6 to< 13 Years Old) With Central Nervous System Disorders
Status: Enrolling
Updated: 12/31/1969
Trial to Assess the Pharmacokinetics, Safety, Tolerability of Oral Brexpiprazole in Children (6 to <13 Years Old) With Central Nervous System Disorders
Updated: 12/31/1969
A Phase 1, Single-dose, Sequential Cohort, Nonrandomized Crossover Trial to Assess the Pharmacokinetics, Safety, and Tolerability of Oral Brexpiprazole in Children (6 to< 13 Years Old) With Central Nervous System Disorders
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Trial to Assess the Pharmacokinetics, Safety, Tolerability of Oral Brexpiprazole in Children (6 to <13 Years Old) With Central Nervous System Disorders
Updated: 12/31/1969
A Phase 1, Single-dose, Sequential Cohort, Nonrandomized Crossover Trial to Assess the Pharmacokinetics, Safety, and Tolerability of Oral Brexpiprazole in Children (6 to< 13 Years Old) With Central Nervous System Disorders
Status: Enrolling
Updated: 12/31/1969
Trial to Assess the Pharmacokinetics, Safety, Tolerability of Oral Brexpiprazole in Children (6 to <13 Years Old) With Central Nervous System Disorders
Updated: 12/31/1969
A Phase 1, Single-dose, Sequential Cohort, Nonrandomized Crossover Trial to Assess the Pharmacokinetics, Safety, and Tolerability of Oral Brexpiprazole in Children (6 to< 13 Years Old) With Central Nervous System Disorders
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Trial to Assess the Pharmacokinetics, Safety, Tolerability of Oral Brexpiprazole in Children (6 to <13 Years Old) With Central Nervous System Disorders
Updated: 12/31/1969
A Phase 1, Single-dose, Sequential Cohort, Nonrandomized Crossover Trial to Assess the Pharmacokinetics, Safety, and Tolerability of Oral Brexpiprazole in Children (6 to< 13 Years Old) With Central Nervous System Disorders
Status: Enrolling
Updated: 12/31/1969
Trial to Assess the Pharmacokinetics, Safety, Tolerability of Oral Brexpiprazole in Children (6 to <13 Years Old) With Central Nervous System Disorders
Updated: 12/31/1969
A Phase 1, Single-dose, Sequential Cohort, Nonrandomized Crossover Trial to Assess the Pharmacokinetics, Safety, and Tolerability of Oral Brexpiprazole in Children (6 to< 13 Years Old) With Central Nervous System Disorders
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Trial to Assess the Pharmacokinetics, Safety, Tolerability of Oral Brexpiprazole in Children (6 to <13 Years Old) With Central Nervous System Disorders
Updated: 12/31/1969
A Phase 1, Single-dose, Sequential Cohort, Nonrandomized Crossover Trial to Assess the Pharmacokinetics, Safety, and Tolerability of Oral Brexpiprazole in Children (6 to< 13 Years Old) With Central Nervous System Disorders
Status: Enrolling
Updated: 12/31/1969
Trial to Assess the Pharmacokinetics, Safety, Tolerability of Oral Brexpiprazole in Children (6 to <13 Years Old) With Central Nervous System Disorders
Updated: 12/31/1969
A Phase 1, Single-dose, Sequential Cohort, Nonrandomized Crossover Trial to Assess the Pharmacokinetics, Safety, and Tolerability of Oral Brexpiprazole in Children (6 to< 13 Years Old) With Central Nervous System Disorders
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Trial to Assess the Pharmacokinetics, Safety, Tolerability of Oral Brexpiprazole in Children (6 to <13 Years Old) With Central Nervous System Disorders
Updated: 12/31/1969
A Phase 1, Single-dose, Sequential Cohort, Nonrandomized Crossover Trial to Assess the Pharmacokinetics, Safety, and Tolerability of Oral Brexpiprazole in Children (6 to< 13 Years Old) With Central Nervous System Disorders
Status: Enrolling
Updated: 12/31/1969
Trial to Assess the Pharmacokinetics, Safety, Tolerability of Oral Brexpiprazole in Children (6 to <13 Years Old) With Central Nervous System Disorders
Updated: 12/31/1969
A Phase 1, Single-dose, Sequential Cohort, Nonrandomized Crossover Trial to Assess the Pharmacokinetics, Safety, and Tolerability of Oral Brexpiprazole in Children (6 to< 13 Years Old) With Central Nervous System Disorders
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Trial to Assess the Pharmacokinetics, Safety, Tolerability of Oral Brexpiprazole in Children (6 to <13 Years Old) With Central Nervous System Disorders
Updated: 12/31/1969
A Phase 1, Single-dose, Sequential Cohort, Nonrandomized Crossover Trial to Assess the Pharmacokinetics, Safety, and Tolerability of Oral Brexpiprazole in Children (6 to< 13 Years Old) With Central Nervous System Disorders
Status: Enrolling
Updated: 12/31/1969
Trial to Assess the Pharmacokinetics, Safety, Tolerability of Oral Brexpiprazole in Children (6 to <13 Years Old) With Central Nervous System Disorders
Updated: 12/31/1969
A Phase 1, Single-dose, Sequential Cohort, Nonrandomized Crossover Trial to Assess the Pharmacokinetics, Safety, and Tolerability of Oral Brexpiprazole in Children (6 to< 13 Years Old) With Central Nervous System Disorders
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Trial to Assess the Pharmacokinetics, Safety, Tolerability of Oral Brexpiprazole in Children (6 to <13 Years Old) With Central Nervous System Disorders
Updated: 12/31/1969
A Phase 1, Single-dose, Sequential Cohort, Nonrandomized Crossover Trial to Assess the Pharmacokinetics, Safety, and Tolerability of Oral Brexpiprazole in Children (6 to< 13 Years Old) With Central Nervous System Disorders
Status: Enrolling
Updated: 12/31/1969
Trial to Assess the Pharmacokinetics, Safety, Tolerability of Oral Brexpiprazole in Children (6 to <13 Years Old) With Central Nervous System Disorders
Updated: 12/31/1969
A Phase 1, Single-dose, Sequential Cohort, Nonrandomized Crossover Trial to Assess the Pharmacokinetics, Safety, and Tolerability of Oral Brexpiprazole in Children (6 to< 13 Years Old) With Central Nervous System Disorders
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials